Member Info for Chris0123

Vander - yes, an easy flow of money may well move things along somewhat but ultimately every element of the science and every sapect of patient health combined with statutory reviews AND COMPLIANCE

Notposting you stated in one of your posts:

"I genuinely believe this could attract interest from a major partner or acquirer because the science has potential"

Could you elaborate on why you make that statement with as many words as you used within that actual post.

DSMB was noted in the 17th Sept RNS. My reading of it is, and someone will correct me no doubt, that data will have been undergoing review throughout the cohort. the data would be live. so it is not a case of them getting it all at once, having to form a Board and then arranging a meeting. The process is slicker than that and we are dealing with sick people so it has to be efficient.

So, they have had 3 weeks + 2 days since the RNS. As we know, these things ALWAYS take longer than anticipated but the optimist in me predicts next week. Have a good weekend all.

Damn AI :)

Every Lidl helps!

AI search characteristics "private investor traders"

- people who wait outside the grounds of airports befoe pick ups to save a couple of quid on parking

- dilute washing up liquid to make it last

- drive 15 miles to save 1p a litre on petrol

- fare dodgers

- shop at Aldi and Lidl

- coast their car downhill to save fuel

- put margarine in a butter dish

- cannot resist telling you about their wee trades

I could go on.

Https://www.statnews.com/2025/10/09/pharmaceutical-industry-infectious-disease-research-global-south/

Notposting are you going to contribute anything this day that is worth reading?

We are intelligent people and don't need you to moderate this forum. Not that I think you are motivated by any sense of benevolence to real investors.

The company is doing very well thank you, just let it be!

Originally posted on 7th July but worth a reminder and a reason why I think how fantastic the paediatric trials are going to be. .

"The 2nd Patient was infused on 2nd May - Paediatric amendment filed 14th May. P2 had barely gotten through 2 weeks before the application to extend the trial to children. However, the staggering bit is that the clinicians did not wait until the 14th May (RNS amendment date) and think "Hey, we'll submit a protocol change to include paediatrics to the FDA" - they would have been working on it and using data pretty much from just Patient 1. What does that tell us about their confidence in the safety & efficacy results in P1. "

So I say, the jump to paediatrics was on Patient 1 data almost exclusively. That, against a backdrop now of P3 getting a glowing report with no evidence of the cancer cells on normal assessment and so bullish are they, they report this fact in an RNS.

Yep, cheers Tilly

Not intending to fall out with you as a poster Westy and no one particularly wants this in the thread I am sure. However, I am not American, thankfully, and whilst direct I used "they" not "you" and as far as I know it's libel if written down and you can't defame a group of people anyway.

That said, I am glad you got your answer and wish you no ill will. Back to Hemo eh!

The only takeover people are concerned about is this board by Aldebaran. Hence the hostility.

Westy go ask Hemogenyx there's noonei obligated to do other people's research. This is what gets me, like a Aldebaran they throw in things to create doubt and uncertainty because if they really cared they would go and find out the answers themselves. Try it some of you.

Aldebaran - it doesn't take a genius to work out that by the laws of probability you will be right on some things. However, the reason is you have a comment about everything and I mean absolutely EVERYTHING. Bomber Harris we should call you, the blanket poster. Furthermore, you subtly feed off the intelligence and research of others and make it your own. Not as a researcher but as a plagiarist. Not sure you have ever taken us to a link following hours of research that might help investors or say something about the industry within which Hemo operate. It's all out of your big knowitall effing head. You mention Avacta constantly like deranged Norman Bates' sexual infatuation with his mother. You say too much and you say it too often - ease up for Heaven's sake.

Https://www.ravimiamet.ee/en/news/new-possibilities-advanced-therapy-medicinal-products-estonia

When will we see an RNS for IRB approval for cohort 2? Here is my working theory. 1. The facts: The FDA gave paediatric approval on 17th June. M D Anderson have 5 IRB Boards running throughout each year EVERY MONTH. IRB 1 & IRB 2 - 1st & 3rd Wed of each month; IRB 3 - 2nd & 3rd Wed of each month; IRB 4 - 1st & 3rd Thursday and IRB 5 - 2nd & 4th Thursday. 2. The application submission date unknown but from 17th June to 24th September. Working days = 72; For a FULL BOARD REVIEW as it involves children this could take 4-6 weeks. Assuming 6 weeks = 30 working days this leaves 42 days to make the application which is a reasonable assumption. (We can't use cohort 1 as a benchmark as there were site problems at Penn) So, if we assume 30 days since the application this would take us in front of IRB 3 on 23rd September (yesterday) or IRB 5 on 25th September (Thursday). (The IRB - 4 sat on 18th but i think we would have heard the result by now. Therefore, my calculation is this Friday 25th September for an RNS as a result of either IRB 3 sitting on 23rd or IRB 5 sitting on 25th. Yep that's my considered view THIS FRIDAY. The IRB RNS came for cohort 1 on a Friday but no IRB Board sits on a Friday so that means at least a 1 day lag before reporting the Board decision. Assumptions are all IRB Boards sat and the application to go in took around 42 days for FDA cohort 2 approval. There is a FULL board review required because children are involved as consents / processing paperwork are a feature of the application process and vulnerability of that age group. If AH wants to run a book put me down for this Friday (with a small each way bet on tomorrow. Definitely a FOMO 2 days coming.

Diggitt - Aldebaran might survive the super ramper cut but he wouldn't survive the super obnoxious cut for all of the reasons many have said.

You have a habit of posting this or something similar on a different site. 4 different companies each on another site in the last 6 or 7 posts you have done. .

We are not interested. This is the Hemo board.

Have to agree with Checkricky 100%. Never doubted Tilly as anything other than being a true investor. However, the motives of people who are not investors suddenly appearing at the sniff of good news stinks. Go and plague environmentally suspect companies, not a healthcare company about to treat children.

At the very least, find a moral compass you can use.

By tomorrow morning 7 am the DCNY Summit will be well over.

We could possibly see an RNS in the morning, detailing a few operational steps forward. Investment / partnership extremely unlikely at this early stage unless he had tee's a few up.

VS may well have wanted to keep his powder dry on a few things to land at the Summit itself. Any interested parties will be aware of any RNS's being published. GLA

Only joking - that will be a good watch, Disease x that is!

I can catch up on Corrie, I have the Box Set- had to evict the kids out of 3 bedrooms to store it.